About Photolitec
Photolitec is a company based in Buffalo (United States) founded in 2010. It operates as a B2B. Photolitec has raised $5 million across 5 funding rounds from investors including HHS, Ami organics and Huahai Pharmaceutical. Photolitec operates in a competitive market with competitors including ImaginAb, AC Immune, PhotoPharmics, APRINOIA and BioArctic, among others.
- Headquarter Buffalo, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 5 rounds
-
Latest Funding Round
$1.36 M (USD), Grant
Sep 07, 2020
-
Investors
HHS
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Photolitec
Unlock access to complete
Unlock access to complete
Funding Insights of Photolitec
Photolitec has successfully raised a total of $5M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $1.36 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Photolitec
Photolitec has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include HHS, Ami organics and Huahai Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Advanced API intermediates are manufactured for pharmaceutical use.
|
Locked | Locked | Locked | |
|
Pharmaceutical APIs, formulations, and animal health products are manufactured.
|
Locked | Locked | Locked |
Investor details for Photolitec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Photolitec
Investment portfolio details for Photolitec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Photolitec
Detailed financials for Photolitec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Photolitec Comparisons
Peer comparison for Photolitec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Photolitec
Photolitec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, PhotoPharmics, APRINOIA and BioArctic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Disease-modifying treatments for neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Radioactive molecular imaging agents for cancer are developed.
|
Detailed competitors of Photolitec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Photolitec
Complete news archive for Photolitec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Photolitec
Photolitec was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Photolitec is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
Photolitec is a funded company, having raised a total of $5M across 5 funding rounds to date.
Photolitec, founded in 2010 in Buffalo, United States, focuses on providing healthcare solutions, advancing biotech innovations, medical imaging, and cancer therapy. Supplies photosensitizing compounds for tumor imaging and photodynamic cancer therapy. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Photolitec's top competitors include ImaginAb, AC Immune and PhotoPharmics.
Photolitec has 4 investors. Key investors include HHS, Ami organics, Huahai Pharmaceutical, and Zhejiang Hisun Pharmaceuticals.